TrialDiabetes, obesity & metabolism2019

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).

Richard E Pratley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.